The role of gut microbiota, butyrate and proton pump inhibitors in amyotrophic lateral sclerosis: a systematic review

Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity

(2019) Yong-Jie Zhang et al.   SCIENCE

Sa1908 – Aberrant Enteric Neuromuscular System and Dysbiosis in Mice with Amyotrophic Lateral Sclerosis

(2019) Yong-Guo Zhang et al.   GASTROENTEROLOGY

Potential Role of the Gut Microbiome in ALS: A Systematic Review

(2018) Michelle L. Wright et al.   Biological Research for Nursing

Bacteroidetes Neurotoxins and Inflammatory Neurodegeneration

(2018) Yuhai Zhao et al.   MOLECULAR NEUROBIOLOGY

Metabolomics activity screening for identifying metabolites that modulate phenotype

(2018) Carlos Guijas et al.   NATURE BIOTECHNOLOGY

The fecal microbiome of ALS patients

(2018) David Brenner et al.   NEUROBIOLOGY OF AGING

Gut microbiota associations with common diseases and prescription medications in a population-based cohort

(2018) Matthew A. Jackson et al.   Nature Communications

Circadian Rhythm Dysfunction Accelerates Disease Progression in a Mouse Model With Amyotrophic Lateral Sclerosis

(2018) Zhilin Huang et al.   Frontiers in Neurology

Extensive impact of non-antibiotic drugs on human gut bacteria

(2018) Lisa Maier et al.   NATURE

The gut microbiome and neuroinflammation in amyotrophic lateral sclerosis? Emerging clinical evidence

(2018) Christina N. Fournier et al.   NEUROBIOLOGY OF DISEASE

Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS

(2018) Débora Lanznaster et al.   Frontiers in Neurology

Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanisms

(2017) Lap Ho et al.   Expert Review of Neurotherapeutics

Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer

(2017) Manasi S Shah et al.   GUT

The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases

(2017) Susanne Krasemann et al.   IMMUNITY

Differential contribution of microglia and monocytes in neurodegenerative diseases

(2017) Caroline Baufeld et al.   JOURNAL OF NEURAL TRANSMISSION

Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study

(2017) Shelly L. Gray et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Motor neuron disease: Peripheral immune cell levels correlate with disease progression in ALS

(2017) Peter Sidaway   Nature Reviews Neurology

Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan

(2017) Shu-Yu Tai et al.   PLoS One

The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches

(2017) Maria Concetta Geloso et al.   Frontiers in Aging Neuroscience

Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanisms

(2017) Lap Ho et al.   Expert Review of Neurotherapeutics

Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression

(2017) Benjamin J. Murdock et al.   JAMA Neurology

Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?

(2017) Christopher P. Webster et al.   Frontiers in Molecular Neuroscience

Colonic Butyrate-Producing Communities in Humans: an Overview Using Omics Data

(2017) Marius Vital et al.   mSystems

Gut microbiota, 1013 new pieces in the Parkinsonʼs disease puzzle

(2016) Filip Scheperjans   CURRENT OPINION IN NEUROLOGY

Gut microbiota in early pediatric multiple sclerosis: a case−control study

(2016) H. Tremlett et al.   EUROPEAN JOURNAL OF NEUROLOGY

Gut microbiota composition and relapse risk in pediatric MS: A pilot study

(2016) Helen Tremlett et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?

(2016) Megan W. Bourassa et al.   NEUROSCIENCE LETTERS

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls

(2016) Marcus M. Unger et al.   PARKINSONISM & RELATED DISORDERS

Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing

(2016) Xin Fang et al.   Frontiers in Microbiology

Association of Proton Pump Inhibitors With Risk of Dementia

(2016) Willy Gomm et al.   JAMA Neurology

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls

(2016) Jun Chen et al.   Scientific Reports

Proton pump inhibitors affect the gut microbiome

(2015) Floris Imhann et al.   GUT

Proton pump inhibitors alter the composition of the gut microbiota

(2015) Matthew A Jackson et al.   GUT

Associations between co-medications and survival in ALS—a cohort study from Austria

(2015) Hakan Cetin et al.   JOURNAL OF NEUROLOGY

Colonic bacterial composition in Parkinson's disease

(2015) Ali Keshavarzian et al.   MOVEMENT DISORDERS

Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS

(2015) Mercedes Prudencio et al.   NATURE NEUROSCIENCE

Risk of dementia in elderly patients with the use of proton pump inhibitors

(2014) Britta Haenisch et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

A Phylogenomic View of Ecological Specialization in the Lachnospiraceae, a Family of Digestive Tract-Associated Bacteria

(2014) Conor J. Meehan et al.   Genome Biology and Evolution

Dysregulation of the homeostatic microglia signature in germ-free mice

(2014) Charlotte Madore et al.   JOURNAL OF NEUROIMMUNOLOGY

Gut microbiota are related to Parkinson's disease and clinical phenotype

(2014) Filip Scheperjans et al.   MOVEMENT DISORDERS

The epidemiology of ALS: a conspiracy of genes, environment and time

(2013) Ammar Al-Chalabi et al.   Nature Reviews Neurology

Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis

(2013) Philippe Corcia et al.   PLoS One

Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases?

(2013) Walter G. Bradley et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Treatment for Helicobacter pylori infection and risk of parkinson’s disease in Denmark

(2012) H. H. Nielsen et al.   EUROPEAN JOURNAL OF NEUROLOGY

Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis

(2012) Elijah W. Stommel et al.   MEDICAL HYPOTHESES

Diversity, stability and resilience of the human gut microbiota

(2012) Catherine A. Lozupone et al.   NATURE

Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease

(2011) Thomas Philips et al.   LANCET NEUROLOGY

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

(2011) Amanda M Haidet-Phillips et al.   NATURE BIOTECHNOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE